Intractable haematuria: long-term results after selective embolization of the internal iliac arteries
- PMID: 20128777
- DOI: 10.1111/j.1464-410X.2009.09192.x
Intractable haematuria: long-term results after selective embolization of the internal iliac arteries
Abstract
Objective: To determine the feasibility and efficacy of transarterial embolization (TAE) in haemorrhagic urological emergencies, and to assess the perioperative morbidity, effect of timing of intervention on the requirement for blood transfusion, and the long-term follow-up.
Patients and methods: Between October 1997 and March 2009, 44 patients (30 men and 14 women; mean age 79 years, range 51-95) with intractable haematuria secondary to advanced pelvic tumour arising from or invading the bladder, underwent internal iliac TAE. Twenty-four patients had transitional carcinoma of the urinary bladder, 12 adenocarcinoma of the prostate, five carcinoma of the uterus, one cancer of the vagina, two carcinoma of the rectum, three carcinoma of the kidney, two simultaneous carcinoma of prostate and bladder, one simultaneous carcinoma of prostate and kidney and one had haemorrhagic cystitis after radiotherapy.
Results: TAE of the internal iliac arteries produced initial complete control of bleeding in 36 of the 44 patients (82%). At a mean (range) follow-up of 10.5 (1-97) months TAE there was permanent control of bleeding in 19 (43%) patients. A second TAE session was use in five (11%) patients and it was successful in two of them. There were 24 patients (55%) who required a mean of 4 (1-17) transfusion units before embolization; only 13 (30%) required more blood products after TAE. The mean haematocrit level before and after TAE was 27% and 31% (P < 0001), and the respective haemoglobin level were 8.7 and 10.3 g/dL (P < 0001). During the follow-up there were no major complications related to TAE; minor complications were post-TAE syndrome in 12 (27%) patients, fever (11%), gluteus pain (14%), nausea (2%), and exterior genital oedema (5%). The 6- and 12-month mortality rates were 66% (29 patients) and 18% (eight), respectively.
Conclusions: TAE should be considered as an alternative less-invasive palliative measure and the treatment of choice in these situations. TAE should always be bilateral, the catheter should advance distally to the origin of the superior gluteal artery and the artery embolized with unresorbable particles. Our study confirms the efficacy and safety of TAE in patients with pelvic malignancy, and indicates that this technique should be considered before surgery. The procedure combines the benefits of a minimally invasive approach in decreasing the cost of surgery and operating time, while maintaining low blood loss and analgesia requirement.
Similar articles
-
[Hypogastric artery embolization as a palliative treatment for bleeding secondary to intractable bladder or prostate disease].Arch Esp Urol. 2003 Mar;56(2):111-8. Arch Esp Urol. 2003. PMID: 12731436 Review. Spanish.
-
Endovascular control of haemorrhagic urological emergencies: an observational study.BMC Urol. 2006 Sep 28;6:27. doi: 10.1186/1471-2490-6-27. BMC Urol. 2006. PMID: 17007647 Free PMC article.
-
Therapeutic transcatheter arterial embolization in the management of intractable haemorrhage from pelvic urological malignancies: preliminary experience and long-term follow-up.BJU Int. 2003 Aug;92(3):245-7. doi: 10.1046/j.1464-410x.2003.04328.x. BJU Int. 2003. PMID: 12887476
-
Internal iliac artery embolization for the control of severe bladder hemorrhage secondary to carcinoma: long-term follow-up.ScientificWorldJournal. 2007 Sep 17;7:1567-74. doi: 10.1100/tsw.2007.229. ScientificWorldJournal. 2007. PMID: 17891317 Free PMC article.
-
Uterine artery embolization as a treatment option for uterine myomas.Obstet Gynecol Clin North Am. 2006 Mar;33(1):125-44. doi: 10.1016/j.ogc.2005.12.009. Obstet Gynecol Clin North Am. 2006. PMID: 16504811 Review.
Cited by
-
Primary non-Hodgkin's lymphoma of the prostate with intractable hematuria: A case report and review of the literature.Oncol Lett. 2015 Mar;9(3):1187-1190. doi: 10.3892/ol.2014.2829. Epub 2014 Dec 24. Oncol Lett. 2015. PMID: 25663879 Free PMC article.
-
Minimizing Blood Loss in Bladder Cancer: Efficacy of Preoperative Embolization before Transurethral Resection of Bladder Tumor.J Korean Soc Radiol. 2025 Jul;86(4):512-523. doi: 10.3348/jksr.2024.0148. Epub 2025 Jul 25. J Korean Soc Radiol. 2025. PMID: 40787298 Free PMC article.
-
Successful minimally-invasive management of a case of giant prostatic hypertrophy associated with recurrent nephrogenic adenoma of the prostate.BMC Urol. 2013 Apr 8;13:18. doi: 10.1186/1471-2490-13-18. BMC Urol. 2013. PMID: 23565707 Free PMC article.
-
Analysis of prognostic factors in patients diagnosed with bladder cancer complicated by hemorrhage treated by drug-eluting bead embolization.Transl Androl Urol. 2023 Nov 30;12(11):1697-1707. doi: 10.21037/tau-23-506. Epub 2023 Nov 9. Transl Androl Urol. 2023. PMID: 38106678 Free PMC article.
-
Selective embolisation for intractable bladder haemorrhages: A systematic review of the literature.Arab J Urol. 2018 Mar 2;16(2):197-205. doi: 10.1016/j.aju.2018.01.004. eCollection 2018 Jun. Arab J Urol. 2018. PMID: 29892482 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical